Position history for BAKER BROS. ADVISORS LP's holdings in ENLIVEN THERAPEUTICS INC
BAKER BROS. ADVISORS LP holds 905,191 shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $35.5M as of 2026-Q1. The position was increased (+233.5% shares). ELVN represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$35.5M
Current Shares
905,191
Total Value Change
+$32.8M
Total Shares Change
+790,358
Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc
Increased |
| 905,191 |
+233.5% |
| $35.5M |
| 0.2% |
| $28.75 |
56 |
| 2025-Q4 | Increased | 271,406 | +136.3% | $4.2M | 0.0% | $15.55 | 43 |
| 2025-Q3 | Unchanged | 114,833 | 0.0% | $2.4M | 0.0% | $20.30 | 0 |
| 2025-Q2 | Unchanged | 114,833 | 0.0% | $2.3M | 0.0% | $20.68 | 0 |
| 2025-Q1 | Unchanged | 114,833 | 0.0% | $2.3M | 0.0% | $21.07 | 0 |
| 2024-Q4 | Unchanged | 114,833 | 0.0% | $2.6M | 0.0% | $22.39 | 0 |
| 2024-Q3 | Unchanged | 114,833 | 0.0% | $2.9M | 0.0% | $24.13 | 0 |
| 2024-Q2 | Unchanged | 114,833 | 0.0% | $2.7M | 0.0% | $23.37 | 0 |